and commensal human enterobacteria. Colibactin-producing gut microbes promote 27 colon tumor formation and enhance progression of colorectal cancer (CRC) via DNA 28 double-strand breaks (DSBs)-induced cellular senescence and death; however, the 29 chemical basis contributing to the pathogenesis at the molecular level remains elusive. 30 Here we report the discovery and the mechanism of action of colibactin-645 as the 31 highly sought final colibactin metabolite with a novel molecular scaffold. 32 Colibactin-645 recapitulates its previously assumed genotoxicity and cytotoxicity, 33 exhibiting a strong DNA DSBs activity in vitro and in human cell cultures via a 34 unique copper-mediated oxidative mechanism. We also present a complete model for 35 colibactin biosynthesis, revealing an unprecedented dual function of the 36 aminomalonate-utilizing polyketide synthases. This work thus provides the first 37 molecular basis for colibactin's genotoxic activity and facilitates further mechanistic 38 study of colibactin-related CRC incidence and prevention. Human microbiota is a massive consortium of all microbes that reside in and on 43 human bodies. These microbes are increasingly being correlated to human health and 44 disease, but the underlying molecular mechanisms of human-microbe interactions 45 often remain elusive 1,2 . Interrogating the specialized metabolites produced by human 46 microbiota allows a thorough study of chemical regulatory and signaling processes, 47 and improves our understanding of the interplay between microbiota and host at a 48 molecular level. Despite the importance of these small molecules in human health and 49 disease, it is often challenging to characterize them because of the difficulty in the 50 culture and genetics of producing microbes and the low titers of these metabolites [3] [4] [5] . 51 A well-known example of such specialized metabolite is colibactin, a cryptic 52 human gut bacterial genotoxin that has captured the attention of both biologists and 53 chemists due to its significant effects on human health and intriguing biosynthetic 54 logic 6-8 . The biosynthesis of colibactin is linked to a 54-kilobase nonribosomal 55 peptide synthetase (NRPS)-polyketide synthase (PKS) hybrid gene cluster 9 (clb 56 pathogenicity island), which has been phenotypically associated with the pathogenesis 57 of colorectal cancer (CRC). In particular, in vitro infection with Escherichia coli 58 strains harboring clb induced DNA double-strand breaks (DSBs) in cultivated human 59 cells, leading to cell cycle arrest and eventually cell death 9 . Subsequent physiological 60 studies showed that clb + bacteria induced in vivo DNA damage and genomic 61 instability in enterocytes 10 , caused cellular senescence 11, 12 , increased intestinal 62 permeability 13 , and promoted colon tumor formation in mouse models of chronic 63 intestinal inflammation 12, 14, 15 , suggesting that these bacteria could promote human 64 CRC development on a broader level 8 . Consistently, clb + E. coli was over-represented 65 in biopsies isolated from CRC patients compared to non-CRC controls (~60% vs. 66~2 0%, respectively) 14, 16 . In addition to its remarkable association with human health, 67 the clb island was also identified in the genomes of other proteobacteria, including 68 coral and honeybee symbionts, suggesting an even more comprehensive role that 69 colibactin might play in mediating evolutionarily conserved or consistent interactions 70 between bacteria and hosts 17,18 . 71 Given the physiological importance of intestinal pathology induced by human 72 body's microscopic residents, it is urgent to reveal the molecular identity of genotoxic 73 colibactin as the missing link between certain gut microbes and DNA DSBs and 74 decode the mechanism underlying colibactin-induced DNA damage. Despite 75 tremendous efforts, colibactin's structural elucidation remains a formidable challenge 76 due to its instability, low titer, and the elusive and complex biosynthetic logic of clb 77 pathway 19-29 . This knowledge gap has prevented comprehensive studies of 78 colibactin-related CRC incidence and prevention, and limited mechanistic 79 investigations of even more extensive influence of clb island on microbe-host 80 interactions. 81 In order to investigate the corresponding genotoxic colibactin that possesses 82 intrinsic DNA DSBs activity and causes chromosome aberrations, the following three 83 3 issues need to be addressed. 1) The mutation of individual clb genes revealed that all 84 genes encoding NRPS-PKS and associated biosynthetic enzymes were indispensable 85 to the genotoxicity of clb island 9,26 , however, the final colibactin metabolite that 86 requires all of the clb genes for its biogenesis has not been identified.
2) The precise 87 role of ClbP, a membrane-bound peptidase that was proposed to be important for 88 colibactin maturation 19,20 , remains unknown. 3) The induction of DNA DSBs has been 89 defined as a signature feature of clb island 6-10 , yet the conclusive evidence for 90 colibactin directly mediating DNA breakage is still lacking, despite that 91 precolibactin-546 (5) showed a weak DNA crosslinking activity in vitro in the 92 presence of reducing agents 24 ( Fig. 1a ). Of the many types of DNA damage that exist 93 within cells, the DNA DSBs are considered to be the most hazardous lesions 30 , 94 suggesting the remarkable cytotoxicity of the yet-to-be-identified colibactin 95 metabolite. Here we report the structural elucidation of the final mature colibactin, 96 and further show that colibactin induces DNA DSBs in vitro and in various human 97 cell cultures via a unique copper-mediated oxidative mechanism. 98 99
Results

100
Discovery of complete colibactin precursor 101 Our previous efforts to identify colibactin biosynthetic intermediates resulted in 102 the structural elucidation of precolibactin-886 (10) 28 , which was isolated from a clb + 103 heterologous expression strain E. coli DH10B/pCAP01-clb with disrupted clbP and 104 clbQ that encode a peptidase and a type II thioesterase mediating the off-loading of 105 clb pathway intermediates, respectively 19,28,31 (Fig. 1 ). The double mutation of 106 ΔclbPΔclbQ increased the titer of downstream metabolites from the NRPS-PKS 107 assembly line, enabling the structural characterization of 10 whose biogenesis 108 requires all components of the assembly line except the PKS ClbO 28 . We then 109 searched for a more complete colibactin derivative that could account for the activity 110 of ClbO. The initial examination of the ΔclbPΔclbQ and ΔclbPΔclbQΔclbO mutants 111 for the selective loss of metabolites identified a precolibactin metabolite with m/z 970 112 (named precolibactin-969, 11) in a trace amount ( Fig. 1, Fig. 2a ). To facilitate the 113 structural elucidation of 11, additional regulatory/resistance clb genes including clbR 114 and clbS were explored to probe their effects on the production of 11. ClbR is a 115 known positive transcriptional regulator and its overexpression previously led to a 116 five-fold increase in the prodrug motif accumulation 22 , and ClbS is a colibactin 117 resistance protein that was proposed to sequester or modify colibactin and thereby 118 prevent self-inflicted DNA damage 32,33 . While overexpression of clbR had no obvious 119 effect on the titer of 11, inactivation of clbS resulted in a notable four-fold increase in 120 the titer of 11 along with other precolibactins (Fig. 2a ). The observed eliciting 121 phenomenon in ΔclbS is consistent with the proposed function of ClbS, and we thus 122 used the ΔclbPΔclbQΔclbS mutant strain for the subsequent precolibactin production 123 and purification. 124 4 From a 2,000-L fermentation culture of ΔclbPΔclbQΔclbS, 50 µg of 11 was 125 obtained after extraction with organic solvent followed by multiple rounds of 126 reversed-phase liquid chromatography purification. 11 was isolated as white and 127 amorphous powder, and its molecular formula was determined as C44H59N9O12S2 by 128 high-resolution mass spectrometry (HRMS) (m/z 970.3799, calculated: 970.3797), 129 which has an additional C3HNO2 compared to the formula of 10. The presence of an 130 extra nitrogen atom in 11 is consistent with the known aminomalonate substrate 131 utilization by ClbO 26, 27 , which was also supported by the isotope-labeled precursor 132 feeding experiments, suggesting the incorporation of an additional aminomalonate 133 compared to 10. Similar to 10, 11 was isolated as an approximately equal mixture of 134 two isomers. Analysis of extensive nuclear magnetic resonance (NMR) spectra and 135 high-resolution tandem mass spectrometry (HRMS n ) fragmentation data demonstrated 136 that 11 and 10 share the same macrocyclic scaffold from C-1 to C-40 ( Fig. 1 ), 137 indicating that ClbO functions towards the end of the NRPS-PKS assembly line to 138 incorporate the last building monomer of aminomalonate. However, we were not able 139 to assign the structure of this extra region (C-41 to C-44) based on the NMR spectra 140 due to the apparent proton deficiency feature and the extremely low titer of 11 at this 141 stage. 142 We then turned to the PKS activity of ClbO to predict the fate of the of ClbJ, followed by synchronous cyclization and release ( Fig. 1, Fig. 2d ). This novel 165 biosynthetic logic of accommodating a rare aminomalonate building block by PKS 166 was further supported by the gene inactivation and isotope labeled precursor feeding 167 5 experiments ( Fig. 2c ). We thus deduce that 11 contains the same 5-hydroxy oxazole 168 moiety next to its terminal carboxyl group, which is derived from the aminomalonate 169 extender unit of ClbO and formed through the same chemical logic as in 8 (Fig. 1, Fig.   170 2e). The discovery of 8 suggests the dual function of aminomalonate-utilizing PKSs 171 in promoting both the C−C and C−N bond formations in colibactin biosynthesis. 172 Indeed, a precolibactin metabolite (precolibactin-943, 12) with m/z 944 corresponding 173 to the decarboxylative condensation activity of ClbO was also observed, but its titer 174 was only approximately 10% of that of 11. Colibactin production by a native strain 198 We next investigated whether the native clb + E. coli strain could produce the 199 same colibactin-645 to probe if 13 was a native metabolite or an artifact arising from 200 a non-natural biosynthetic pathway in a heterologous host. LC-MS analysis of 201 cell-free culture extracts of the wild-type clb + E. coli CFT073 and its clbmutant 202 revealed a peak identical to 13 only in the wild-type clb + strain, confirming that 13 is 203 the native product of the clb pathogenicity island (Fig. 3b ). It is notable that after 204 enrichment from a 2-L of fermentation culture, only a trace amount of 13 was 205 detected by HRMS analysis, indicating the low titer of 13 or its chemical lability. 206 Since previous work showed that direct contact between bacterial and eukaryotic cells 207 6 was required for full toxicity of colibactin 9 , we further examined whether a majority 208 of 13 are associated with the producing cells. 13 was not detected in the cellular 209 extract of clb + E. coli CFT073 (Fig. 3b ), suggesting that the mature colibactin was 210 secreted after production and highly unstable after secretion. (Fig. 4c) . Surprisingly, the presence of a reducing agent, such as 241 β-mercaptoethanol (β-ME) or dithiothreitol (DTT), had no obvious effect on the 242 DSBs activity of 11 (Fig. 4c ). We thus propose that the reduction of Cu(II) to Cu(I) 243 may be mediated by the DNA or by 11 itself, and the latter was supported by the free The oxidative mechanism of DNA cleavage was further probed by adding 255 various reactive oxygen species (ROS) scavengers. Plasmid DNA damage by 11 was 256 not measurably influenced by the hydroxyl radical scavengers mannitol and dimethyl 257 sulfoxide (DMSO) (Fig. 4d ), which argues against participation of the freely 258 diffusible hydroxyl radical in the observed cleavage and distinguishes the mechanism 259 by which colibactin incises DNA from a sole Fenton-like one 41 . The addition of 260 superoxide dismutase (SOD), which catalyzes the conversion of the superoxide 261 radical into hydrogen peroxide (H2O2), did not measurably influence DNA cleavage 262 by 11 ( Fig. 4d ). In contrast, potassium iodide (KI), a H2O2 scavenger, and catalase, 263 which mediates the decomposition of H2O2, significantly inhibited the cleavage 264 reaction (Fig. 4d) . These results suggested that H2O2 was involved in mediating DNA 13 or the infection of clb + E. coli CFT073 (Fig. 5c, d) , which is in agreement with the 306 observed dependence of copper for colibactin-induced DNA DSBs in vitro. 4°C after binding to a reduced transition metal 45 . In addition to the low abundance 326 and chemical lability, the macrocyclic mature colibactin appeared to be polar 327 compound that stayed in the aqueous phase during organic solvent extraction, which 328 could further contribute to the difficulty in the genotoxic metabolite detection. is yet to be determined the molecular basis for these PKSs to prefer one mechanism 343 over the other in producing 13 as the major genotoxic metabolite. 344 Based on the DNA damage assays both in vitro and in cells, we propose the 345 following mechanism for copper-mediated DNA DSBs by colibactin-645 (13). After 
